Clinical significance of oxidation and acetylation genetic polymorphism in patients with Parkinson's disease;Kliniczne znaczenie polimorfizmu oksydacji sparteiny i acetylacji sulfadimidyny u chorych na chorobe Parkinsona.

Neurologia i neurochirurgia polska

Volumn 33, Issue 5, 1999, Pages 1015-1024

  Milejski, P ^a   Orzechowska Juzwenko, K ^a   Kamienowski, J ^a   Horoch, E ^a   Niewinski P ^a   Hurkacz, M ^a   Rzemislawska Z ^a  

^a Katedry i Zak adu Farmakologii Klinicznej AM we Wroc awiu

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; SPARTEINE; SULFADIMIDINE;

ACETYLATION; ADULT; AGED; ARTICLE; COMPARATIVE STUDY; FEMALE; GENETIC POLYMORPHISM; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; OXIDATION REDUCTION REACTION; PARKINSON DISEASE; PHENOTYPE; URINE;

ACETYLATION; ADULT; AGED; ANTI-INFECTIVE AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATION-REDUCTION; PARKINSON DISEASE; PHENOTYPE; POLYMORPHISM, GENETIC; SPARTEINE; SULFAMETHAZINE;

EID: 0033182336     PISSN: 00283843     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)